• About us
• Contact

Advertisement

Product › Details

FAVORITE technology (Flow and VOlume Regulated Inhalation TEchnology)

	Next higher product group	respiratory drug delivery technology_o
	Status	2013-04-23 existent
	Organisation	Activaero GmbH
	Group	Vectura (Group)

Record changed: 2023-07-10

Advertisement

More documents for respiratory drug delivery technology

• [1] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
• [2] AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich....
• [3] Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich....
• [4] Voluntis S.A.. (7/23/21). "Press Release: Voluntis Announces the Execution of a Share Purchase Agreement between Its Reference Shareholders and Aptar Regarding the Acquisition of a Majority Stake in Voluntis at a Price of €8.70 per Share". Cambridge, MA...
• [5] Philip Morris International Inc.. (7/9/21). "Press Release: Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc". New York, NY....
• [6] Voluntis S.A.. (6/22/21). "Press Release: Exclusive Negotiations Regarding a Potential Acquisition of Voluntis by Aptar to Expand in Digital Therapeutics". Cambridge, MA & Paris....
• [7] Relief Therapeutics Holding AG. (1/20/21). "Press Release: Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil". Geneva & Gundelfingen....
• [8] Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan....
• [9] Breath Therapeutics B.V.. (3/26/19). "Press Release: Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome". Munich & Menlo Park, CA....
• [10] Breath Therapeutics B.V.. (10/17/18). "Press Release: Breath Therapeutics Appoints Peter Shadday as Chief Commercial Officer". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.